Skip to main content
letter
. 2016 Sep 1;33(5):581–582. doi: 10.5152/balkanmedj.2016.151651

TABLE 1.

Clinical characteristics, pathological features and treatment of patients with testicular Hodgkin’s lymphoma in the literature (3).

Author Age Clinical information Site (testis) HL subtype IHC Stage Treatment Outcome
Our case 40 Cervical, mediastinal, abdominal mass, testicular involvement(relapse) Bilateral MC CD15 (+) IVB CT (6xABVD) CR (DFS 1 years)
Ben Ameur El Youbi and Errihani (3) 17 Cervical mass, Empty scrotum (initial involvement) Left NS CD15 (+)
CD30 (+) IVB Orchiectomy + CT (8xABVD) CR (DFS 2 years)
Gatt et al. (1) 73 Testicular mass (initial involvement) Right NS CD3 (+) IVA Orchiectomy (Not taken CT) Died before CT
CD15 (+)
CD30 (+)
Seliem et al. (2) 52 Testicular mass (initial involvement) Left Classical CD15 (+) IVB Orchiectomy + CT(4xABVD and 2xAVD) CR (Not reached)
CD30 (+)
Glaholm et al. (4) 56 Scrotal pain (initial involvement), Axillary node Right MC np IVA Orchiectomy + CT (6xChlVPP) CR (DFS 3 years)
Vishniavsky et al. (5) 79 Inguinal mass (initial involvement) Right Hodgkin sarcoma (autopsy) np - - Died before treatment

HL: Hodgkin’s lymphoma; IHC: immunohistochemistry; NS: nodular sclerosis; MC: mixed cellularity; np: not performed; CT: chemotherapy; ABVD: doxorubicin, bleomycin, vinblastine, dacarbazine; AVD: doxorubicin, vinblastine, dacarbazine; ChlVPP : chlorambucil, vinblastine procarbazine, prednisolone; CR: complete response; DFS: disease free survival.